nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—Status epilepticus—Temozolomide—malignant glioma	0.0232	0.036	CcSEcCtD
Zalcitabine—Tonic-clonic seizures—Carmustine—malignant glioma	0.021	0.0326	CcSEcCtD
Zalcitabine—VIIth nerve paralysis—Carmustine—malignant glioma	0.0138	0.0214	CcSEcCtD
Zalcitabine—Grand mal convulsion—Carmustine—malignant glioma	0.0119	0.0185	CcSEcCtD
Zalcitabine—Nephropathy toxic—Carmustine—malignant glioma	0.00985	0.0153	CcSEcCtD
Zalcitabine—Cerebration impaired—Temozolomide—malignant glioma	0.0093	0.0144	CcSEcCtD
Zalcitabine—Haemorrhoids—Temozolomide—malignant glioma	0.0093	0.0144	CcSEcCtD
Zalcitabine—Aphasia—Carmustine—malignant glioma	0.00872	0.0136	CcSEcCtD
Zalcitabine—Aphasia—Temozolomide—malignant glioma	0.00843	0.0131	CcSEcCtD
Zalcitabine—Parosmia—Temozolomide—malignant glioma	0.00843	0.0131	CcSEcCtD
Zalcitabine—Hypokinesia—Carmustine—malignant glioma	0.00838	0.013	CcSEcCtD
Zalcitabine—Paranoia—Carmustine—malignant glioma	0.0083	0.0129	CcSEcCtD
Zalcitabine—Myopathy—Temozolomide—malignant glioma	0.00779	0.0121	CcSEcCtD
Zalcitabine—Influenza-like symptoms—Temozolomide—malignant glioma	0.00765	0.0119	CcSEcCtD
Zalcitabine—Stupor—Carmustine—malignant glioma	0.00758	0.0118	CcSEcCtD
Zalcitabine—Rigors—Temozolomide—malignant glioma	0.0067	0.0104	CcSEcCtD
Zalcitabine—Speech disorder—Carmustine—malignant glioma	0.00658	0.0102	CcSEcCtD
Zalcitabine—Liver injury—Temozolomide—malignant glioma	0.0065	0.0101	CcSEcCtD
Zalcitabine—Speech disorder—Temozolomide—malignant glioma	0.00636	0.00988	CcSEcCtD
Zalcitabine—Disturbance in attention—Temozolomide—malignant glioma	0.00631	0.00981	CcSEcCtD
Zalcitabine—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00601	0.00934	CcSEcCtD
Zalcitabine—Coordination abnormal—Carmustine—malignant glioma	0.00576	0.00895	CcSEcCtD
Zalcitabine—Hearing impaired—Temozolomide—malignant glioma	0.00574	0.00892	CcSEcCtD
Zalcitabine—Neck pain—Carmustine—malignant glioma	0.00573	0.0089	CcSEcCtD
Zalcitabine—Coordination abnormal—Temozolomide—malignant glioma	0.00557	0.00865	CcSEcCtD
Zalcitabine—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00547	0.00849	CcSEcCtD
Zalcitabine—Depressed level of consciousness—Carmustine—malignant glioma	0.00546	0.00849	CcSEcCtD
Zalcitabine—Candida infection—Carmustine—malignant glioma	0.0054	0.00839	CcSEcCtD
Zalcitabine—Skin exfoliation—Carmustine—malignant glioma	0.0054	0.00839	CcSEcCtD
Zalcitabine—Influenza like illness—Temozolomide—malignant glioma	0.00531	0.00825	CcSEcCtD
Zalcitabine—Depressed level of consciousness—Temozolomide—malignant glioma	0.00528	0.0082	CcSEcCtD
Zalcitabine—Candida infection—Temozolomide—malignant glioma	0.00522	0.00811	CcSEcCtD
Zalcitabine—Skin exfoliation—Temozolomide—malignant glioma	0.00522	0.00811	CcSEcCtD
Zalcitabine—Vaginal infection—Temozolomide—malignant glioma	0.00516	0.00802	CcSEcCtD
Zalcitabine—Dry eye—Temozolomide—malignant glioma	0.00505	0.00785	CcSEcCtD
Zalcitabine—Abnormal vision—Carmustine—malignant glioma	0.00493	0.00767	CcSEcCtD
Zalcitabine—Mental disability—Carmustine—malignant glioma	0.00491	0.00763	CcSEcCtD
Zalcitabine—Abnormal vision—Temozolomide—malignant glioma	0.00477	0.00741	CcSEcCtD
Zalcitabine—Mental disability—Temozolomide—malignant glioma	0.00474	0.00737	CcSEcCtD
Zalcitabine—Diabetes mellitus—Carmustine—malignant glioma	0.00472	0.00734	CcSEcCtD
Zalcitabine—Swelling—Carmustine—malignant glioma	0.00465	0.00723	CcSEcCtD
Zalcitabine—Ear pain—Temozolomide—malignant glioma	0.00465	0.00723	CcSEcCtD
Zalcitabine—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00456	0.00709	CcSEcCtD
Zalcitabine—Eye pain—Carmustine—malignant glioma	0.00455	0.00707	CcSEcCtD
Zalcitabine—Deafness—Temozolomide—malignant glioma	0.00444	0.00689	CcSEcCtD
Zalcitabine—Vascular purpura—Temozolomide—malignant glioma	0.00444	0.00689	CcSEcCtD
Zalcitabine—Eye pain—Temozolomide—malignant glioma	0.0044	0.00683	CcSEcCtD
Zalcitabine—Amnesia—Carmustine—malignant glioma	0.00437	0.00679	CcSEcCtD
Zalcitabine—Hot flush—Temozolomide—malignant glioma	0.00424	0.00659	CcSEcCtD
Zalcitabine—Amnesia—Temozolomide—malignant glioma	0.00422	0.00656	CcSEcCtD
Zalcitabine—Menopausal symptoms—Temozolomide—malignant glioma	0.00421	0.00653	CcSEcCtD
Zalcitabine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00421	0.00653	CcSEcCtD
Zalcitabine—Hyponatraemia—Carmustine—malignant glioma	0.00412	0.00641	CcSEcCtD
Zalcitabine—Purpura—Temozolomide—malignant glioma	0.00412	0.0064	CcSEcCtD
Zalcitabine—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00411	0.00638	CcSEcCtD
Zalcitabine—Affect lability—Temozolomide—malignant glioma	0.00391	0.00607	CcSEcCtD
Zalcitabine—Ataxia—Carmustine—malignant glioma	0.00386	0.006	CcSEcCtD
Zalcitabine—Mood swings—Temozolomide—malignant glioma	0.00376	0.00584	CcSEcCtD
Zalcitabine—Hypokalaemia—Carmustine—malignant glioma	0.00374	0.00581	CcSEcCtD
Zalcitabine—Ataxia—Temozolomide—malignant glioma	0.00373	0.0058	CcSEcCtD
Zalcitabine—Dry skin—Temozolomide—malignant glioma	0.00364	0.00565	CcSEcCtD
Zalcitabine—Muscular weakness—Carmustine—malignant glioma	0.00362	0.00563	CcSEcCtD
Zalcitabine—Hypokalaemia—Temozolomide—malignant glioma	0.00361	0.00561	CcSEcCtD
Zalcitabine—Dysphagia—Carmustine—malignant glioma	0.00355	0.00551	CcSEcCtD
Zalcitabine—Muscular weakness—Temozolomide—malignant glioma	0.0035	0.00544	CcSEcCtD
Zalcitabine—Abdominal distension—Temozolomide—malignant glioma	0.00345	0.00536	CcSEcCtD
Zalcitabine—Dysphagia—Temozolomide—malignant glioma	0.00343	0.00533	CcSEcCtD
Zalcitabine—Sweating increased—Temozolomide—malignant glioma	0.00334	0.00519	CcSEcCtD
Zalcitabine—Neutropenia—Carmustine—malignant glioma	0.00332	0.00516	CcSEcCtD
Zalcitabine—Neutropenia—Temozolomide—malignant glioma	0.00321	0.00498	CcSEcCtD
Zalcitabine—Dysuria—Temozolomide—malignant glioma	0.00321	0.00498	CcSEcCtD
Zalcitabine—Hyperglycaemia—Carmustine—malignant glioma	0.0032	0.00497	CcSEcCtD
Zalcitabine—Pollakiuria—Temozolomide—malignant glioma	0.00317	0.00492	CcSEcCtD
Zalcitabine—Depression—Carmustine—malignant glioma	0.00316	0.0049	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Temozolomide—malignant glioma	0.00313	0.00486	CcSEcCtD
Zalcitabine—Weight decreased—Temozolomide—malignant glioma	0.0031	0.00482	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Carmustine—malignant glioma	0.0031	0.00482	CcSEcCtD
Zalcitabine—Hyperglycaemia—Temozolomide—malignant glioma	0.00309	0.00481	CcSEcCtD
Zalcitabine—Depression—Temozolomide—malignant glioma	0.00305	0.00474	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Temozolomide—malignant glioma	0.003	0.00466	CcSEcCtD
Zalcitabine—Sinusitis—Temozolomide—malignant glioma	0.00287	0.00446	CcSEcCtD
Zalcitabine—Hallucination—Carmustine—malignant glioma	0.00283	0.00439	CcSEcCtD
Zalcitabine—Hepatitis—Temozolomide—malignant glioma	0.00275	0.00427	CcSEcCtD
Zalcitabine—Visual impairment—Carmustine—malignant glioma	0.00274	0.00425	CcSEcCtD
Zalcitabine—Hallucination—Temozolomide—malignant glioma	0.00273	0.00424	CcSEcCtD
Zalcitabine—Pharyngitis—Temozolomide—malignant glioma	0.00272	0.00423	CcSEcCtD
Zalcitabine—Eye disorder—Carmustine—malignant glioma	0.00265	0.00412	CcSEcCtD
Zalcitabine—Visual impairment—Temozolomide—malignant glioma	0.00265	0.00411	CcSEcCtD
Zalcitabine—Flushing—Carmustine—malignant glioma	0.00264	0.0041	CcSEcCtD
Zalcitabine—Eye disorder—Temozolomide—malignant glioma	0.00257	0.00399	CcSEcCtD
Zalcitabine—Tinnitus—Temozolomide—malignant glioma	0.00256	0.00398	CcSEcCtD
Zalcitabine—Flushing—Temozolomide—malignant glioma	0.00255	0.00396	CcSEcCtD
Zalcitabine—Arrhythmia—Carmustine—malignant glioma	0.00254	0.00394	CcSEcCtD
Zalcitabine—Alopecia—Carmustine—malignant glioma	0.00251	0.0039	CcSEcCtD
Zalcitabine—Chills—Temozolomide—malignant glioma	0.00246	0.00383	CcSEcCtD
Zalcitabine—Alopecia—Temozolomide—malignant glioma	0.00243	0.00377	CcSEcCtD
Zalcitabine—Back pain—Carmustine—malignant glioma	0.00239	0.00372	CcSEcCtD
Zalcitabine—Dysgeusia—Temozolomide—malignant glioma	0.00234	0.00364	CcSEcCtD
Zalcitabine—Vision blurred—Carmustine—malignant glioma	0.00233	0.00362	CcSEcCtD
Zalcitabine—Tremor—Carmustine—malignant glioma	0.00232	0.0036	CcSEcCtD
Zalcitabine—Back pain—Temozolomide—malignant glioma	0.00231	0.00359	CcSEcCtD
Zalcitabine—Anaemia—Carmustine—malignant glioma	0.00229	0.00355	CcSEcCtD
Zalcitabine—Agitation—Carmustine—malignant glioma	0.00227	0.00353	CcSEcCtD
Zalcitabine—Vision blurred—Temozolomide—malignant glioma	0.00225	0.0035	CcSEcCtD
Zalcitabine—Tremor—Temozolomide—malignant glioma	0.00224	0.00348	CcSEcCtD
Zalcitabine—Ill-defined disorder—Temozolomide—malignant glioma	0.00222	0.00345	CcSEcCtD
Zalcitabine—Leukopenia—Carmustine—malignant glioma	0.00221	0.00344	CcSEcCtD
Zalcitabine—Anaemia—Temozolomide—malignant glioma	0.00221	0.00343	CcSEcCtD
Zalcitabine—Agitation—Temozolomide—malignant glioma	0.0022	0.00341	CcSEcCtD
Zalcitabine—Malaise—Temozolomide—malignant glioma	0.00215	0.00335	CcSEcCtD
Zalcitabine—Vertigo—Temozolomide—malignant glioma	0.00215	0.00334	CcSEcCtD
Zalcitabine—Convulsion—Carmustine—malignant glioma	0.00214	0.00333	CcSEcCtD
Zalcitabine—Leukopenia—Temozolomide—malignant glioma	0.00214	0.00332	CcSEcCtD
Zalcitabine—Hypertension—Carmustine—malignant glioma	0.00213	0.00332	CcSEcCtD
Zalcitabine—Palpitations—Temozolomide—malignant glioma	0.00211	0.00328	CcSEcCtD
Zalcitabine—Myalgia—Carmustine—malignant glioma	0.00211	0.00327	CcSEcCtD
Zalcitabine—Anxiety—Carmustine—malignant glioma	0.0021	0.00326	CcSEcCtD
Zalcitabine—Cough—Temozolomide—malignant glioma	0.00209	0.00324	CcSEcCtD
Zalcitabine—Convulsion—Temozolomide—malignant glioma	0.00207	0.00322	CcSEcCtD
Zalcitabine—Hypertension—Temozolomide—malignant glioma	0.00206	0.00321	CcSEcCtD
Zalcitabine—Confusional state—Carmustine—malignant glioma	0.00203	0.00316	CcSEcCtD
Zalcitabine—Arthralgia—Temozolomide—malignant glioma	0.00203	0.00316	CcSEcCtD
Zalcitabine—Myalgia—Temozolomide—malignant glioma	0.00203	0.00316	CcSEcCtD
Zalcitabine—Anxiety—Temozolomide—malignant glioma	0.00203	0.00315	CcSEcCtD
Zalcitabine—Oedema—Carmustine—malignant glioma	0.00202	0.00314	CcSEcCtD
Zalcitabine—Discomfort—Temozolomide—malignant glioma	0.00201	0.00312	CcSEcCtD
Zalcitabine—Infection—Carmustine—malignant glioma	0.002	0.00312	CcSEcCtD
Zalcitabine—Dry mouth—Temozolomide—malignant glioma	0.00199	0.00309	CcSEcCtD
Zalcitabine—Thrombocytopenia—Carmustine—malignant glioma	0.00198	0.00307	CcSEcCtD
Zalcitabine—Tachycardia—Carmustine—malignant glioma	0.00197	0.00306	CcSEcCtD
Zalcitabine—Confusional state—Temozolomide—malignant glioma	0.00197	0.00306	CcSEcCtD
Zalcitabine—Oedema—Temozolomide—malignant glioma	0.00195	0.00303	CcSEcCtD
Zalcitabine—Infection—Temozolomide—malignant glioma	0.00194	0.00301	CcSEcCtD
Zalcitabine—Anorexia—Carmustine—malignant glioma	0.00192	0.00299	CcSEcCtD
Zalcitabine—Thrombocytopenia—Temozolomide—malignant glioma	0.00191	0.00297	CcSEcCtD
Zalcitabine—Skin disorder—Temozolomide—malignant glioma	0.00189	0.00294	CcSEcCtD
Zalcitabine—Hyperhidrosis—Temozolomide—malignant glioma	0.00189	0.00293	CcSEcCtD
Zalcitabine—Anorexia—Temozolomide—malignant glioma	0.00186	0.00289	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00184	0.00286	CcSEcCtD
Zalcitabine—Insomnia—Carmustine—malignant glioma	0.00183	0.00284	CcSEcCtD
Zalcitabine—Dyspnoea—Carmustine—malignant glioma	0.0018	0.0028	CcSEcCtD
Zalcitabine—Somnolence—Carmustine—malignant glioma	0.00179	0.00279	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00178	0.00276	CcSEcCtD
Zalcitabine—Insomnia—Temozolomide—malignant glioma	0.00176	0.00274	CcSEcCtD
Zalcitabine—Decreased appetite—Carmustine—malignant glioma	0.00175	0.00273	CcSEcCtD
Zalcitabine—Dyspnoea—Temozolomide—malignant glioma	0.00174	0.0027	CcSEcCtD
Zalcitabine—Somnolence—Temozolomide—malignant glioma	0.00173	0.00269	CcSEcCtD
Zalcitabine—Pain—Carmustine—malignant glioma	0.00173	0.00268	CcSEcCtD
Zalcitabine—Dyspepsia—Temozolomide—malignant glioma	0.00172	0.00267	CcSEcCtD
Zalcitabine—Decreased appetite—Temozolomide—malignant glioma	0.0017	0.00263	CcSEcCtD
Zalcitabine—Fatigue—Temozolomide—malignant glioma	0.00168	0.00261	CcSEcCtD
Zalcitabine—Pain—Temozolomide—malignant glioma	0.00167	0.00259	CcSEcCtD
Zalcitabine—Feeling abnormal—Carmustine—malignant glioma	0.00166	0.00258	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Carmustine—malignant glioma	0.00165	0.00256	CcSEcCtD
Zalcitabine—Feeling abnormal—Temozolomide—malignant glioma	0.00161	0.0025	CcSEcCtD
Zalcitabine—Body temperature increased—Carmustine—malignant glioma	0.0016	0.00248	CcSEcCtD
Zalcitabine—Abdominal pain—Carmustine—malignant glioma	0.0016	0.00248	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00159	0.00248	CcSEcCtD
Zalcitabine—Urticaria—Temozolomide—malignant glioma	0.00155	0.00241	CcSEcCtD
Zalcitabine—Abdominal pain—Temozolomide—malignant glioma	0.00154	0.0024	CcSEcCtD
Zalcitabine—Body temperature increased—Temozolomide—malignant glioma	0.00154	0.0024	CcSEcCtD
Zalcitabine—Hypersensitivity—Carmustine—malignant glioma	0.00149	0.00231	CcSEcCtD
Zalcitabine—Asthenia—Carmustine—malignant glioma	0.00145	0.00225	CcSEcCtD
Zalcitabine—Hypersensitivity—Temozolomide—malignant glioma	0.00144	0.00223	CcSEcCtD
Zalcitabine—Asthenia—Temozolomide—malignant glioma	0.0014	0.00217	CcSEcCtD
Zalcitabine—Diarrhoea—Carmustine—malignant glioma	0.00138	0.00215	CcSEcCtD
Zalcitabine—Pruritus—Temozolomide—malignant glioma	0.00138	0.00214	CcSEcCtD
Zalcitabine—Dizziness—Carmustine—malignant glioma	0.00133	0.00207	CcSEcCtD
Zalcitabine—Diarrhoea—Temozolomide—malignant glioma	0.00133	0.00207	CcSEcCtD
Zalcitabine—Dizziness—Temozolomide—malignant glioma	0.00129	0.002	CcSEcCtD
Zalcitabine—Vomiting—Carmustine—malignant glioma	0.00128	0.00199	CcSEcCtD
Zalcitabine—Rash—Carmustine—malignant glioma	0.00127	0.00198	CcSEcCtD
Zalcitabine—Dermatitis—Carmustine—malignant glioma	0.00127	0.00198	CcSEcCtD
Zalcitabine—Headache—Carmustine—malignant glioma	0.00126	0.00196	CcSEcCtD
Zalcitabine—Vomiting—Temozolomide—malignant glioma	0.00124	0.00193	CcSEcCtD
Zalcitabine—Rash—Temozolomide—malignant glioma	0.00123	0.00191	CcSEcCtD
Zalcitabine—Dermatitis—Temozolomide—malignant glioma	0.00123	0.00191	CcSEcCtD
Zalcitabine—Headache—Temozolomide—malignant glioma	0.00122	0.0019	CcSEcCtD
Zalcitabine—SLC22A7—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000655	0.00184	CbGpPWpGaD
Zalcitabine—CYP3A7—Biological oxidations—GSTT1—malignant glioma	0.000652	0.00183	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—COX8A—malignant glioma	0.000652	0.00183	CbGpPWpGaD
Zalcitabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000629	0.00177	CbGpPWpGaD
Zalcitabine—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000621	0.00174	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000614	0.00172	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000614	0.00172	CbGpPWpGaD
Zalcitabine—CYP3A7—Biological oxidations—PTGS1—malignant glioma	0.000611	0.00171	CbGpPWpGaD
Zalcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	0.000606	0.0017	CbGpPWpGaD
Zalcitabine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000591	0.00166	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000588	0.00165	CbGpPWpGaD
Zalcitabine—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000586	0.00164	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000584	0.00164	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—CYP2C18—malignant glioma	0.000583	0.00164	CbGpPWpGaD
Zalcitabine—CYP3A5—Metapathway biotransformation—CYP2C18—malignant glioma	0.000575	0.00161	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ASMT—malignant glioma	0.000563	0.00158	CbGpPWpGaD
Zalcitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000555	0.00156	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ASMT—malignant glioma	0.000554	0.00155	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000537	0.00151	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—BCAN—malignant glioma	0.000529	0.00148	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—APOD—malignant glioma	0.000522	0.00146	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—BCAN—malignant glioma	0.000521	0.00146	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00051	0.00143	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000483	0.00135	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	0.000478	0.00134	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.000474	0.00133	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	0.000471	0.00132	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—GSTT1—malignant glioma	0.000471	0.00132	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.000467	0.00131	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.00046	0.00129	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—RTEL1—malignant glioma	0.000457	0.00128	CbGpPWpGaD
Zalcitabine—CYP3A7—Biological oxidations—GSTP1—malignant glioma	0.000452	0.00127	CbGpPWpGaD
Zalcitabine—CYP3A7—Metapathway biotransformation—GSTP1—malignant glioma	0.000446	0.00125	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—PTGS1—malignant glioma	0.000442	0.00124	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—IDH2—malignant glioma	0.000426	0.0012	CbGpPWpGaD
Zalcitabine—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000425	0.00119	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—IDH2—malignant glioma	0.00042	0.00118	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	0.000414	0.00116	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.000411	0.00115	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	0.000409	0.00115	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000405	0.00114	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP2B6—malignant glioma	0.000401	0.00112	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP2B6—malignant glioma	0.000395	0.00111	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000387	0.00108	CbGpPWpGaD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000382	0.00107	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000381	0.00107	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—IDH1—malignant glioma	0.000367	0.00103	CbGpPWpGaD
Zalcitabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000366	0.00103	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—IDH1—malignant glioma	0.000361	0.00101	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—SPHK1—malignant glioma	0.000355	0.000995	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00035	0.000981	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—SPHK1—malignant glioma	0.000349	0.00098	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP2C18—malignant glioma	0.000348	0.000975	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP2C18—malignant glioma	0.000342	0.00096	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—GSTT1—malignant glioma	0.000335	0.00094	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000333	0.000934	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.000332	0.000932	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—RTEL1—malignant glioma	0.00033	0.000927	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—GSTP1—malignant glioma	0.000327	0.000917	CbGpPWpGaD
Zalcitabine—CYP3A5—Metapathway biotransformation—GSTP1—malignant glioma	0.000322	0.000904	CbGpPWpGaD
Zalcitabine—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000321	0.000899	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—PTGS1—malignant glioma	0.000314	0.000881	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000313	0.000877	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.000311	0.000874	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000308	0.000865	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GSTT1—malignant glioma	0.000281	0.000789	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GSTT1—malignant glioma	0.000277	0.000777	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000271	0.00076	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000267	0.00075	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000267	0.00075	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000265	0.000743	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTGS1—malignant glioma	0.000263	0.000739	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—COX8A—malignant glioma	0.000262	0.000736	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTGS1—malignant glioma	0.000259	0.000728	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000245	0.000688	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—BCHE—malignant glioma	0.000245	0.000687	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—SLC5A5—malignant glioma	0.000242	0.000679	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—BCHE—malignant glioma	0.000241	0.000677	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—SLC5A5—malignant glioma	0.000238	0.000668	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—RTEL1—malignant glioma	0.000235	0.000659	CbGpPWpGaD
Zalcitabine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000234	0.000658	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000234	0.000655	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000233	0.000653	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—GSTP1—malignant glioma	0.000232	0.000652	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.00023	0.000646	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	0.000229	0.000643	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000227	0.000637	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ASMT—malignant glioma	0.000223	0.000626	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000219	0.000615	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—BCAN—malignant glioma	0.00021	0.000589	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000205	0.000576	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GSTP1—malignant glioma	0.000195	0.000547	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GSTP1—malignant glioma	0.000192	0.000538	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—COX8A—malignant glioma	0.00019	0.000532	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CAT—malignant glioma	0.00019	0.000532	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CAT—malignant glioma	0.000187	0.000524	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—NCOR1—malignant glioma	0.000179	0.000502	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—NCOR1—malignant glioma	0.000176	0.000495	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—IDH2—malignant glioma	0.000169	0.000475	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000166	0.000467	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ASMT—malignant glioma	0.000161	0.000453	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000161	0.000452	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP2B6—malignant glioma	0.000159	0.000446	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000154	0.000431	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000152	0.000426	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—BCAN—malignant glioma	0.000152	0.000426	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000151	0.000423	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.00015	0.00042	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CAV1—malignant glioma	0.000146	0.00041	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—IDH1—malignant glioma	0.000145	0.000408	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CAV1—malignant glioma	0.000144	0.000403	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SPHK1—malignant glioma	0.000141	0.000395	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP2C18—malignant glioma	0.000138	0.000387	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—COX8A—malignant glioma	0.000135	0.000379	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—COX8A—malignant glioma	0.000134	0.000375	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CG—malignant glioma	0.000133	0.000373	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CG—malignant glioma	0.000131	0.000367	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PPARG—malignant glioma	0.000128	0.00036	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PPARG—malignant glioma	0.000126	0.000355	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—IDH2—malignant glioma	0.000122	0.000343	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00012	0.000335	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CD—malignant glioma	0.000117	0.000328	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CD—malignant glioma	0.000115	0.000323	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP2B6—malignant glioma	0.000115	0.000323	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ASMT—malignant glioma	0.000115	0.000322	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ASMT—malignant glioma	0.000114	0.000319	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTT1—malignant glioma	0.000112	0.000313	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000111	0.000312	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—BCAN—malignant glioma	0.000108	0.000303	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—BCAN—malignant glioma	0.000107	0.0003	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000106	0.000297	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—IDH1—malignant glioma	0.000105	0.000295	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTGS1—malignant glioma	0.000105	0.000293	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CB—malignant glioma	0.000102	0.000286	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SPHK1—malignant glioma	0.000102	0.000285	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTGS2—malignant glioma	0.000101	0.000283	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CB—malignant glioma	0.0001	0.000282	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP2C18—malignant glioma	9.97e-05	0.00028	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTGS2—malignant glioma	9.94e-05	0.000279	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—BCHE—malignant glioma	9.72e-05	0.000273	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SLC5A5—malignant glioma	9.6e-05	0.000269	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—COX8A—malignant glioma	8.82e-05	0.000247	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTEN—malignant glioma	8.8e-05	0.000247	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—IDH2—malignant glioma	8.69e-05	0.000244	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTEN—malignant glioma	8.67e-05	0.000243	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—IDH2—malignant glioma	8.62e-05	0.000242	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP2B6—malignant glioma	8.17e-05	0.000229	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	8.13e-05	0.000228	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP2B6—malignant glioma	8.1e-05	0.000227	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTT1—malignant glioma	8.06e-05	0.000226	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTP1—malignant glioma	7.73e-05	0.000217	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTGS1—malignant glioma	7.55e-05	0.000212	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CAT—malignant glioma	7.52e-05	0.000211	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ASMT—malignant glioma	7.5e-05	0.00021	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—IDH1—malignant glioma	7.48e-05	0.00021	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—IDH1—malignant glioma	7.41e-05	0.000208	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SPHK1—malignant glioma	7.23e-05	0.000203	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SPHK1—malignant glioma	7.17e-05	0.000201	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NCOR1—malignant glioma	7.1e-05	0.000199	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP2C18—malignant glioma	7.09e-05	0.000199	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—BCAN—malignant glioma	7.05e-05	0.000198	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP2C18—malignant glioma	7.03e-05	0.000197	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—BCHE—malignant glioma	7.02e-05	0.000197	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SLC5A5—malignant glioma	6.94e-05	0.000195	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.63e-05	0.000186	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CA—malignant glioma	6.21e-05	0.000174	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CA—malignant glioma	6.12e-05	0.000172	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.04e-05	0.000169	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.82e-05	0.000163	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CAV1—malignant glioma	5.79e-05	0.000162	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTT1—malignant glioma	5.73e-05	0.000161	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—IDH2—malignant glioma	5.68e-05	0.000159	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTT1—malignant glioma	5.68e-05	0.000159	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTP1—malignant glioma	5.59e-05	0.000157	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CAT—malignant glioma	5.44e-05	0.000153	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTGS1—malignant glioma	5.37e-05	0.000151	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP2B6—malignant glioma	5.34e-05	0.00015	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTGS1—malignant glioma	5.33e-05	0.000149	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.31e-05	0.000149	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CG—malignant glioma	5.27e-05	0.000148	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NCOR1—malignant glioma	5.13e-05	0.000144	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PPARG—malignant glioma	5.09e-05	0.000143	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—AKT1—malignant glioma	5.07e-05	0.000142	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—AKT1—malignant glioma	5e-05	0.00014	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—BCHE—malignant glioma	4.99e-05	0.00014	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—BCHE—malignant glioma	4.95e-05	0.000139	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC5A5—malignant glioma	4.93e-05	0.000138	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC5A5—malignant glioma	4.89e-05	0.000137	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—IDH1—malignant glioma	4.89e-05	0.000137	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SPHK1—malignant glioma	4.73e-05	0.000133	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CD—malignant glioma	4.64e-05	0.00013	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.63e-05	0.00013	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.62e-05	0.00013	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.58e-05	0.000129	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CAV1—malignant glioma	4.19e-05	0.000117	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CB—malignant glioma	4.04e-05	0.000113	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTGS2—malignant glioma	4e-05	0.000112	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4e-05	0.000112	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTP1—malignant glioma	3.97e-05	0.000111	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTP1—malignant glioma	3.94e-05	0.000111	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CAT—malignant glioma	3.87e-05	0.000108	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CAT—malignant glioma	3.83e-05	0.000108	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CG—malignant glioma	3.81e-05	0.000107	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTT1—malignant glioma	3.75e-05	0.000105	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PPARG—malignant glioma	3.68e-05	0.000103	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NCOR1—malignant glioma	3.65e-05	0.000102	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NCOR1—malignant glioma	3.62e-05	0.000102	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTGS1—malignant glioma	3.51e-05	9.85e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTEN—malignant glioma	3.49e-05	9.8e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CD—malignant glioma	3.35e-05	9.4e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—BCHE—malignant glioma	3.26e-05	9.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.22e-05	9.05e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CAV1—malignant glioma	2.98e-05	8.35e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CAV1—malignant glioma	2.95e-05	8.28e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CB—malignant glioma	2.92e-05	8.2e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTGS2—malignant glioma	2.89e-05	8.12e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.82e-05	7.91e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CG—malignant glioma	2.71e-05	7.61e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CG—malignant glioma	2.69e-05	7.54e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PPARG—malignant glioma	2.62e-05	7.34e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTP1—malignant glioma	2.6e-05	7.29e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PPARG—malignant glioma	2.59e-05	7.28e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CAT—malignant glioma	2.53e-05	7.09e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTEN—malignant glioma	2.52e-05	7.08e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CA—malignant glioma	2.46e-05	6.91e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NCOR1—malignant glioma	2.39e-05	6.7e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.38e-05	6.69e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.36e-05	6.63e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.08e-05	5.83e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.06e-05	5.78e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTGS2—malignant glioma	2.06e-05	5.77e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTGS2—malignant glioma	2.04e-05	5.72e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AKT1—malignant glioma	2.01e-05	5.65e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CAV1—malignant glioma	1.95e-05	5.46e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTEN—malignant glioma	1.8e-05	5.04e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.78e-05	5e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTEN—malignant glioma	1.78e-05	4.99e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.77e-05	4.97e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PPARG—malignant glioma	1.71e-05	4.8e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.56e-05	4.37e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AKT1—malignant glioma	1.45e-05	4.08e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.36e-05	3.81e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.35e-05	3.78e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.27e-05	3.55e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.26e-05	3.52e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTEN—malignant glioma	1.17e-05	3.29e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AKT1—malignant glioma	1.03e-05	2.9e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AKT1—malignant glioma	1.03e-05	2.88e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CA—malignant glioma	8.28e-06	2.32e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AKT1—malignant glioma	6.76e-06	1.9e-05	CbGpPWpGaD
